Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	65,058	36,883	25,545	23,695	21,747	18,638
Market Cap Growth	38.25%	44.38%	7.81%	8.96%	16.68%	-14.41%
Enterprise Value	65,912	37,658	26,256	25,227	22,521	19,066
Last Close Price	58.65	33.00	22.72	21.84	19.79	16.76
PE Ratio	182.29	93.27	86.56	85.52	63.02	29.28
Forward PE	123.91	58.20	60.57	69.53	62.77	23.76
PS Ratio	16.12	9.91	7.61	7.86	7.84	5.60
PB Ratio	16.01	8.78	6.13	7.56	7.45	6.53
P/TBV Ratio	23.83	12.56	7.45	10.18	10.07	8.10
P/FCF Ratio	310.02	26513.20	436.15	-	-	-
P/OCF Ratio	95.50	83.44	56.82	250.62	607.43	90.39
EV/Sales Ratio	16.33	10.12	7.83	8.37	8.12	5.73
EV/EBITDA Ratio	158.00	75.57	48.24	79.50	122.44	57.27
EV/EBIT Ratio	-	143.72	79.19	178.20	598.98	83.50
EV/FCF Ratio	314.08	27070.49	448.29	-	-	-
Debt / Equity Ratio	0.57	0.46	0.43	0.67	0.43	0.38
Debt / EBITDA Ratio	5.54	3.76	3.28	6.48	6.55	3.23
Debt / FCF Ratio	11.02	1373.28	30.84	-	-	-
Asset Turnover	0.60	0.55	0.53	0.55	0.56	0.66
Inventory Turnover	3.95	3.84	3.10	3.05	3.91	5.17
Quick Ratio	1.64	1.48	1.50	1.09	0.81	1.04
Current Ratio	1.89	1.74	1.76	1.38	1.02	1.22
Return on Equity (ROE)	10.55%	11.14%	8.09%	12.94%	17.93%	22.98%
Return on Assets (ROA)	1.54%	2.44%	3.26%	1.60%	0.47%	2.84%
Return on Capital (ROIC)	1.69%	2.71%	3.69%	1.88%	0.58%	3.86%
Return on Capital Employed (ROCE)	3.00%	5.00%	6.40%	3.10%	1.10%	7.00%
Earnings Yield	0.55%	1.07%	1.16%	1.17%	1.59%	3.42%
FCF Yield	0.32%	0.00%	0.23%	-2.56%	-3.07%	-2.12%
Dividend Yield	0.71%	1.26%	0.88%	-	0.94%	2.22%
Payout Ratio	138.92%	106.72%	14.43%	89.32%	123.52%	20.54%
Buyback Yield / Dilution	-2.60%	-3.37%	-2.57%	1.17%	0.07%	-0.50%
Total Shareholder Return	-1.90%	-2.11%	-1.69%	1.17%	1.00%	1.72%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.